Yeshiva University: Vaccine Protection Against Herpes
June 05, 2020
June 05, 2020
BRONX, New York, June 5 -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
An effective vaccine against herpes viral infections caused by either HSV-1or HSV-2 remains elusive. Genital herpes (primarily caused by HSV-2) is notorious for promoting HIV infection. It contributes more to the HIV epidemic than any other biological factor.
Mathematical models suggest that vaccinating against HSV-2 could have a major effect on HIV tra . . .
An effective vaccine against herpes viral infections caused by either HSV-1or HSV-2 remains elusive. Genital herpes (primarily caused by HSV-2) is notorious for promoting HIV infection. It contributes more to the HIV epidemic than any other biological factor.
Mathematical models suggest that vaccinating against HSV-2 could have a major effect on HIV tra . . .